Evolva agrees extra funding to support further expansion 11-Jan-2022 By Nicola Gordon-Seymour Swiss biotech company, Evolva, has secured additional funding from investment firm, Nice & Green to accelerate growth in key markets and leverage manufacturing efficiencies.